LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $397,000 | -27.2% | 3,523 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $545,000 | +32.3% | 3,529 | +19.5% | 0.00% | 0.0% |
| Q3 2021 | $412,000 | +14.1% | 2,952 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $361,000 | +34.7% | 2,750 | +56.2% | 0.00% | +100.0% |
| Q1 2021 | $268,000 | -37.5% | 1,760 | -59.2% | 0.00% | -50.0% |
| Q4 2020 | $429,000 | +4.4% | 4,315 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $411,000 | -5.1% | 4,315 | +11.7% | 0.00% | 0.0% |
| Q2 2020 | $433,000 | +52.5% | 3,863 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $284,000 | +3.6% | 3,902 | +291.8% | 0.00% | +100.0% |
| Q3 2018 | $274,000 | +5.0% | 996 | -20.8% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | -0.4% | 1,258 | -20.8% | 0.00% | 0.0% |
| Q1 2018 | $262,000 | -1.9% | 1,588 | -18.4% | 0.00% | 0.0% |
| Q4 2017 | $267,000 | +23.6% | 1,947 | +22.9% | 0.00% | 0.0% |
| Q3 2017 | $216,000 | – | 1,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |